The comparison of efficacy between recombinant activated factor VII (ARYOSEVEN) and NOVOSEVEN in patients with congenital factor VII deficiency

Faranoush M ;
Hassan A ;
Toogeh G ;
Karimi M ;
Eshghi P ;
Managchi MR ;
Hamid H ;
Kamyar K ;
Heshmat R ;
Keykhahi B

Iranian Blood Transfusion Organization; Shahid Beheshti University of Medical Sciences; Tehran University of Medical Sciences, Tehran; Shiraz University of Medical Sciences, Shiraz; Shahid Beheshti University of Medical Sciences, Tehran; Isfahan University of Medical Sciences, Isfahan; AryoGen Biopharma Company, Karaj; Ahvaz University of Medical Sciences, Ahvaz, Iran

Journal of Thrombosis and Haemostasis. 2013;11((S2):):1198. Abstract No. PO 481.